eXp World (EXPI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 Apr, 2026Executive summary
Annual Meeting scheduled for April 24, 2026, with key proposal to redomesticate from Delaware to Texas.
Redomestication aims to provide financial benefits and maintain substantially the same shareholder rights.
Board and Special Committee spent over a year evaluating the move, supported by independent legal counsel.
The process is not a reaction to litigation and does not affect ongoing operations or existing legal matters.
Forward-looking statements highlight potential benefits, risks, and uncertainties related to the redomestication.
Voting matters and shareholder proposals
Proposal 4 seeks approval for redomestication from Delaware to Texas by conversion.
Approval requires both a majority of outstanding shares and a majority of votes cast by disinterested stockholders.
Dual-vote structure exceeds legal requirements, giving non-affiliated holders a decisive voice.
Abstentions and broker non-votes count against statutory approval but not against unaffiliated approval.
Board of directors and corporate governance
Special Committee of independent directors led the review, excluding those named in pending litigation.
No non-ratable benefits identified for directors or officers from the redomestication.
Texas law allows directors to consider interests of key constituencies, aligning with the business model.
Latest events from eXp World
- Shareholders are asked to approve redomestication to Texas, aligning governance with business needs.EXPI
Proxy filing24 Apr 2026 - Shareholders will vote on redomestication to Texas, with key risks and benefits highlighted.EXPI
Proxy filing23 Apr 2026 - Shareholders will vote on redomestication to Texas, with new litigation thresholds and outlined risks.EXPI
Proxy filing23 Apr 2026 - Shareholders are voting on a Texas redomestication, with enhanced governance and voting safeguards.EXPI
Proxy filing23 Apr 2026 - Proxy solicitor engaged for 2026 Annual Meeting to support redomestication vote.EXPI
Proxy filing20 Apr 2026 - Shareholders to vote on Texas redomestication, governance, and compensation changes.EXPI
Proxy Filing9 Mar 2026 - Board recommends approval of director elections, auditor, executive pay, and Texas redomestication.EXPI
Proxy Filing25 Feb 2026 - 2025 revenue rose 4% to $4.8B, with 67% international growth and strong agent productivity.EXPI
Q4 202524 Feb 2026 - Q2 2024 revenue up 5% to $1.3B, adjusted EBITDA up 22%, and $56M returned to shareholders.EXPI
Q2 20242 Feb 2026